Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | TDO2 | P48775 | 2/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19019729 | 0.80 | ADRB2 (0.43) | IDO1TDO2SLC6A4 | |
| SCHEMBL9153510 | 0.80 | ALOX5 (0.33) | SLC6A2SLC6A4SLC6A3HTT | |
| SCHEMBL17520022 | 0.79 | TAAR1 (0.35) | IDO1TDO2 | |
| SCHEMBL19019754 | 0.78 | CA1 (0.42) | CYP17A1ACHEHTT | |
| SCHEMBL19019720 | 0.77 | LMNA (0.39) | — | |
| SCHEMBL29065729 | 0.76 | IDO1 (0.39) | IDO1TDO2CYP17A1AOC3ACHE | |
| SCHEMBL14522308 | 0.72 | ESR1 (0.52) | SLC6A2SLC6A3 | |
| SCHEMBL7063054 | 0.71 | TAAR1 (0.32) | IDO1TDO2 | |
| SCHEMBL26249056 | 0.69 | CA1 (0.46) | CYP17A1ACHEHTT | |
| SCHEMBL84956 | 0.65 | IDO1 (0.46) | IDO1TDO2AOC3ACHEDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184172-B1 | HYDROSILYLATION IRON CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-106573235-B | Iron hydrosilylate catalyst | 国立大学法人九州大学 | 2020-07-07 | — | — | CN | disclosed |
| US-10239896-B2 | Hydrosilylation iron catalyst | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2019-03-26 | — | — | US | disclosed |
| US-20170260216-A1 | HYDROSILYLATION IRON CATALYST | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| EP-3184172-A1 | HYDROSILYLATION IRON CATALYST | Kyushu University, National University Corporation (JP) | 2017-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10239896-B2 | Hydrosilylation iron catalyst | SLC40A1, FTH1, SFXN1 | IDO1 255/4885TDO2 207/4885CYP17A1 1718/4885 |
| US-20170260216-A1 | HYDROSILYLATION IRON CATALYST | SLC40A1, FTH1, SFXN1 | IDO1 255/4885TDO2 207/4885CYP17A1 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.